BPTH Bio-Path Holdings
- 2.760
- -0.240-8.00%
Bio-Path Holdings News
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a po
Express News | Bio-Path Holdings Has Been Granted Israeli Patent Number 269608 Titled "COMPOSITIONS COMPRISING P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION FOR USE IN TREATING CANCER OR AUTOIMMUNE DISEASE"
Looking Into Bio-Path Hldgs's Recent Short Interest
Bio-Path Hldgs's (NYSE:BPTH) short percent of float has fallen 4.27% since its last report. The company recently reported that it has 67 thousand shares sold short, which is 8.96% of all regular share
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.
MRIN, WISA and SMFL Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's market cap stands at $33.7 million. The company's, Q4 earnings came out 4 days ago. MSP Rec
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers
Express News | Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.Wang & Lee Group posted a FY23
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share
Bio-Path Shares Pare Gains on Registered Direct Offering News
By Josh Beckerman Bio-Path Holdings shares pared their gains after the biotechnology company announced a $1.2 million registered direct offering. The stock more than doubled after a favorable Thursd
Express News | Bio-Path Shares Resume Trade Following Circuit Breaker Halt
Express News | Bio Path Holdings- Entered Into Deal With Some Institutional Investors for Sale of 375,000 Shares of Its Common Stock at Price of $3.225/Share
Express News | Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Express News | Roth MKM Reiterates Buy on Bio-Path Hldgs, Maintains $40 Price Target
Bio-Path Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 619.42% Roth MKM → $40 Reiterates Buy → Buy 03/27/2024 619.42% Roth MKM $12 → $40 Maintains Buy
CGC, GENE and HOLO Among Mid-day Movers
Why Bio-Path Stock Is Soaring
Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares are trading higher Thursday after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the abil
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday.The Dow traded up 0.64% to 37,996.39 while the NASDAQ rose 0.41% to 15,747.36. The S&P 500 also rose,
Analysis
Price Target
No Data
